Axsome Therapeutics
Matthew DiStasi possesses extensive experience in quality assurance and compliance within the pharmaceutical and laboratory sectors. Currently serving as Director of Quality Systems & Compliance at Axsome Therapeutics, Inc., Matthew has held various roles including Associate Director and Senior Manager in Quality Assurance since November 2020. Prior to this, Matthew worked at ALK from June 2014 to November 2020 as Quality Assurance Operations Manager and QA Systems Manager, where responsibilities included managing internal audits, developing supplier quality inspection systems, and overseeing quality documentation. Matthew's earlier career includes positions at Pace Analytical, H2M, Hofstra University, Long Island Plastic Surgical Group, and Stony Brook University, demonstrating a solid foundation in laboratory analysis and research. Matthew holds an MBA in Health Care Administration from Capella University and a B.S. in Biochemistry from Hofstra University.
This person is not in any teams
This person is not in any offices
Axsome Therapeutics
5 followers
Axsome Therapeutics develops and commercializes therapies for the management and treatment of pain and other neurological disorders.